Most people understand that alcohol consumption increases the risk of liver disease and certain cancers, but pancreatic cancer stands out as a notable exception. Despite being one of the most lethal forms of cancer, it has never officially been recognized as alcohol-related.
A new analysis argues that this needs to change. After reviewing decades of research findings, Canadian scientists discovered that a long-standing flaw in how alcohol studies are conducted likely obscured the true relationship. The results were published in the International Journal of Alcohol and Drug Research.
Once that distortion was corrected, the evidence pointed to alcohol as a clear risk factor for developing pancreatic cancer.
Few cancers alarm doctors as much as the one that originates in the pancreas. Pancreatic cancer develops silently, deep in the abdominal cavity, and rarely shows symptoms until it has already spread.
The late-stage nature of the disease makes it especially deadly. Only about one in eight individuals survives five years after diagnosis. Globally, according to an overview of worldwide trends, it ranks as the seventh leading cause of cancer deaths.
The question of whether alcohol contributes to this disorder remains unresolved. A team of researchers from the Canadian Institute for Substance Use Research (CISUR) at the University of Victoria, led by institute researcher Jinhui Zhao, set out to find an answer.
A significant portion of the team’s efforts focused on a single overlooked flaw. In numerous studies, the individuals used as a healthy control group—so-called non-drinkers—were often not lifetime abstainers. Not even close.
Many of them were former heavy drinkers who had quit, often because their health was already declining. Counting these individuals as abstainers puts the sicker members of the comparison group at a disadvantage, making those who drink appear better off.
Researchers call this the former drinker bias, and it has quietly distorted the results of alcohol studies for decades.
Zhao has long argued that many who label themselves as abstainers are actually former drinkers who still carry the harmful effects of alcohol, including its link to cancer, thus retaining its consequences.
To filter out the noise emerging from individual studies, the researchers conducted a meta-analysis—a method that combines multiple studies into a single, much larger dataset. A larger dataset makes it easier to identify a genuine pattern.
Their search scope was broad. After reviewing thousands of scientific papers, they selected 37 long-term studies that tracked the health of nearly 21 million people, including approximately 65,000 cases of pancreatic cancer or deaths from it.
A key feature of this work was the approach to selecting study participants. In some studies, former drinkers were not included in the abstainer group; in most, they were.
Analyzing the data separately for the two groups revealed what happens once this error is corrected.
The combined data analysis uncovered a clear pattern. The more alcohol people consumed, the higher their likelihood of developing pancreatic cancer—a consistent trend that held across all methods tested by the team.
One notable jump occurred when a daily threshold was exceeded. Consuming more than 24 grams of alcohol per day—just under two standard drinks—increased the risk by 10 to 30 percent. At lower levels, this effect nearly vanished.
Each additional 10 grams per day raised the risk by about two to three percent. These are associations, not proof. But the increase was steady, with no safe decline along the way.
The most interesting findings emerged when the studies were sorted by quality. In those that misclassified former drinkers, a familiar illusion appeared. Moderate drinkers seemed protected, with their risk dropping by about a tenth compared to non-drinkers. That reduction disappeared once separate studies with stricter standards were examined.
In studies where former drinkers were not included in the abstainer group, no benefit from moderate drinking was observed. Only a consistent rise in risk was seen.
One comparison provided the bulk of the explanation. Scattered hints that one or two alcoholic drinks might protect against pancreatic cancer have confused the science for years, and this work suggests they were never true.
The same blind spot has exaggerated the apparent benefits of alcohol in other areas. A separate analysis of alcohol consumption and mortality rates showed that the advantages of moderate drinking largely disappeared once former drinkers were excluded from the abstainer category.
The reasons why alcohol contributes to this type of cancer are not fully understood, but chemical processes offer strong grounds for further investigation. When the body breaks down alcohol, it produces acetaldehyde—a reactive compound that damages DNA and blocks cellular repair mechanisms.
Both alcohol and acetaldehyde are already classified as carcinogens. A paper on the biological mechanisms of this process describes how damaged DNA and chronic inflammation wear down cells over time. Heavy drinking also causes inflammation of the pancreas, and repeated episodes of inflammation are a known risk factor for cancer.
Which pathway does the most harm remains unclear. The study measured risk, not biological factors.
This analysis indicates that the supposed safe zone for light alcohol consumption, at least for the pancreas, is a measurement error.
Once the counting mistake is corrected, the risk only increases with higher doses.
“It’s time to add pancreatic cancer to the list of alcohol-related cancers,” said Tim Naimi, a physician who leads the institute.
Naimi believes the evidence has finally reached a level where action is necessary.
Pancreatic cancer may begin to appear in cancer risk warnings that some countries print on bottles, and doctors may stop repeating the old saying that an evening drink does no harm.
For researchers, the conclusion is even clearer. Refining the criteria for defining non-drinkers could alter the results of future alcohol studies and reveal what hidden harm old statistics concealed.
About the Author
